ATE165866T1 - Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung - Google Patents

Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung

Info

Publication number
ATE165866T1
ATE165866T1 AT94903752T AT94903752T ATE165866T1 AT E165866 T1 ATE165866 T1 AT E165866T1 AT 94903752 T AT94903752 T AT 94903752T AT 94903752 T AT94903752 T AT 94903752T AT E165866 T1 ATE165866 T1 AT E165866T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
tau protein
pct
antibodies
microtubulus
Prior art date
Application number
AT94903752T
Other languages
English (en)
Inventor
Marc Vandermeeren
Marc Mercken
Eugeen Vanmechelen
De Voorde Andre Van
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE165866T1 publication Critical patent/ATE165866T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94903752T 1992-12-14 1993-12-10 Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung ATE165866T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92403403 1992-12-14

Publications (1)

Publication Number Publication Date
ATE165866T1 true ATE165866T1 (de) 1998-05-15

Family

ID=8211736

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903752T ATE165866T1 (de) 1992-12-14 1993-12-10 Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung

Country Status (9)

Country Link
US (1) US5843779A (de)
EP (1) EP0673418B1 (de)
JP (1) JP2879975B2 (de)
AT (1) ATE165866T1 (de)
AU (1) AU690092B2 (de)
DE (1) DE69318420T2 (de)
DK (1) DK0673418T3 (de)
ES (1) ES2118373T3 (de)
WO (1) WO1994013795A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
WO1993008302A1 (en) * 1991-10-25 1993-04-29 Itt Automotive Europe Gmbh Monoclonal antibodies directed against the microtubule-associated protein tau
US6121003A (en) * 1994-07-29 2000-09-19 Innogentics N.V. Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use
US6797478B1 (en) * 1998-03-05 2004-09-28 University Of Cincinnati Method of detecting axonal damage, from associated disease states using tau monoclonal antibodies
JP4624559B2 (ja) * 1998-09-08 2011-02-02 イノジェネティックス・ナムローゼ・フェンノートシャップ 初期ｃｎｓダメージのマーカーとしてのタウ
EP1169646A2 (de) * 1999-01-25 2002-01-09 Minerva Biotechnologies Corporation Schneller und empfindlicher nachweis fehlerhafter proteinaggregation bei neurodegenerativen erkrankungen
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
CA2397991C (en) 2000-01-24 2017-10-24 Innogenetics N.V. Diagnosis of tauopathies
US20030162230A1 (en) * 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins
WO2004081534A2 (en) * 2003-03-12 2004-09-23 Assay Designs, Inc. Phosphokinase assay
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7238788B2 (en) * 2004-02-18 2007-07-03 University Of Iowa Foundation Antibodies to phosphorylated tau, methods of making and methods of use
US20070178447A1 (en) * 2006-01-31 2007-08-02 Bethyl Laboratories, Inc. Method for decreasing interference in results of immunochemical methods
HUE055739T2 (hu) * 2009-03-18 2021-12-28 Ac Immune Sa Eljárás terápiás alkalmazásra
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CA2813493C (en) 2010-10-11 2019-07-09 University Of Zurich Human anti-tau antibodies
GB201111361D0 (en) 2011-07-04 2011-08-17 Nordic Bioscience As Biochemical markers for neurodegenerative conditions
CN104520322B (zh) 2012-04-05 2019-11-15 Ac免疫有限公司 人源化tau抗体
MY176838A (en) 2012-08-16 2020-08-24 Ipierian Inc Methods of treating a tauopathy
US9200068B2 (en) 2012-12-18 2015-12-01 Regents Of The University Of Minnesota Compositions and methods related to tauopathy
LT2935326T (lt) 2012-12-21 2020-12-10 Biogen Ma Inc. Žmogaus antikūnai prieš tau baltymą
US8980270B2 (en) 2013-01-18 2015-03-17 Ipierian, Inc. Methods of treating a tauopathy
CU24446B1 (es) 2013-03-13 2019-10-04 Prothena Biosciences Ltd Un anticuerpo monoclonal humanizado que se une a tau
KR102233349B1 (ko) 2013-03-15 2021-03-31 에이씨 이뮨 에스.에이. 항-타우(tau) 항체 및 사용 방법
NZ630610A (en) 2014-02-14 2019-05-31 Ipierian Inc Tau peptides, anti-tau antibodies, and methods of use thereof
EP3452508A1 (de) 2016-05-02 2019-03-13 Prothena Biosciences Limited Antikörper zur erkennung von tau
JP7170316B2 (ja) 2016-05-02 2022-11-14 プロセナ バイオサイエンシーズ リミテッド タウ免疫療法
SG11201910066QA (en) 2017-05-02 2019-11-28 Prothena Biosciences Ltd Antibodies recognizing tau
EA202091012A1 (ru) 2017-10-25 2020-08-27 Янссен Фармасьютикалз, Инк. Композиции фосфорилированных тау-пептидов и их применения
EP3885362A4 (de) 2018-11-22 2022-08-17 Fujirebio Inc. Antikörperkonjugat
CN113710269A (zh) 2019-02-08 2021-11-26 Ac免疫有限公司 磷酸化Tau肽疫苗的安全施用方法
WO2020180819A1 (en) 2019-03-03 2020-09-10 Prothena Biosciences Limited Antibodies recognizing tau
EA202192891A1 (ru) 2019-04-24 2022-02-04 Янссен Фармасьютикалз, Инк. Гетерологичное введение анти-тау вакцин
JPWO2021065306A1 (de) * 2019-09-30 2021-04-08
EP4135841A1 (de) 2020-04-15 2023-02-22 Voyager Therapeutics, Inc. Tau-bindende verbindungen
CN111349617B (zh) * 2020-05-25 2020-09-22 苏州仁端生物医药科技有限公司 一种分泌抗Tau或pTau-181/231/396单克隆抗体杂交瘤细胞株及其应用
AU2021403010A1 (en) 2020-12-16 2023-07-13 Voyager Therapeutics, Inc. Tau binding compounds
WO2022144406A1 (en) 2020-12-29 2022-07-07 Neurimmune Ag Human anti-tau antibodies
CN113005096B (zh) * 2021-01-19 2022-10-14 华中科技大学 分泌抗丝氨酸磷酸化tau蛋白单克隆抗体的杂交瘤细胞株
WO2023250388A1 (en) 2022-06-22 2023-12-28 Voyager Therapeutics, Inc. Tau binding compounds
WO2024059739A1 (en) 2022-09-15 2024-03-21 Voyager Therapeutics, Inc. Tau binding compounds

Also Published As

Publication number Publication date
EP0673418B1 (de) 1998-05-06
WO1994013795A1 (en) 1994-06-23
ES2118373T3 (es) 1998-09-16
US5843779A (en) 1998-12-01
JP2879975B2 (ja) 1999-04-05
AU5809794A (en) 1994-07-04
EP0673418A1 (de) 1995-09-27
JPH08502898A (ja) 1996-04-02
DE69318420T2 (de) 1999-01-28
DK0673418T3 (da) 1999-03-01
DE69318420D1 (de) 1998-06-10
AU690092B2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
ATE165866T1 (de) Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
ATE154642T1 (de) Monoklonale antikörper gegen das mikrotubulusassoziierte protein tau.
Hamsten et al. Identification of galactose‐α‐1, 3‐galactose in the gastrointestinal tract of the tick I xodes ricinus; possible relationship with red meat allergy
Plotz et al. Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes
DE69429095T2 (de) Humanisierte antikoerper
DE60112744D1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
ES2161751T3 (es) Anticuerpo monoclonal que se une especificamente al endotelio vascular tumoral y usos del mismo.
GR3025630T3 (en) Monoclonal antibody against human IgE
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
Freysdottir et al. Diversity of γδ T cells in patients with Behcet's disease is indicative of polyclonal activation
Vaerman et al. The IgA system of the guinea pig
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
Quan et al. Human amniotic IgA inhibits natural IgG autoantibodies of maternal or unrelated origin
DE3885975D1 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
CA2150816A1 (en) Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
Sthoeger et al. Anticardiolipin, but not the 166 Id anti-DNA antibody induces pregnancy failure
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
Mellbye et al. Effect of Human Anti‐γ‐Globulin Antibodies on Human Lymphocytes.
ATE455794T1 (de) Monoklonale antikörper gegen humane thymidylat- synthase und hybridomen zu derer herstellung
STOTT et al. Analysis of the autoimmune response to DNA in tolerant mice by isoelectric focusing and reverse immunoblotting. 1: Clonal restriction and time course
TARUMI Immunological studies on lupus nephritis Part 2. Studies on glomerular deposition of C 1 q
ITTO911003A0 (it) Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification